PRRT2 and Parkinson disease: EGCG is of particular interest in the treatment of Alzheimer’s and Parkinson’s diseases because it exhibits neuroprotective effects such as radical scavenging, iron chelating, activation of PKC, and anti-apoptotic action [for review, see (64)].